These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 17426205)

  • 61. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
    Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
    J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.
    Ferran N; Ricart Y; Lopez M; Martinez-Ballarin I; Roca M; Gámez C; Carrerea D; Guirao S; Leon AF; Martin-Comin J
    Nucl Med Commun; 2006 Jun; 27(6):507-14. PubMed ID: 16710105
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
    Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
    Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
    Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
    Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of hemangioma by positron emission tomography: role in a multimodality approach.
    Hatayama K; Watanabe H; Ahmed AR; Yanagawa T; Shinozaki T; Oriuchi N; Aoki J; Takeuchi K; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(1):70-7. PubMed ID: 12544246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient.
    Han EJ; Jang YS; Lee IS; Lee JM; Kang S; Kim HS
    J Korean Med Sci; 2013 Sep; 28(9):1399-402. PubMed ID: 24015050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia.
    de Prost N; Kerrou K; Sibony M; Talbot JN; Wislez M; Cadranel J
    Respiration; 2010; 79(1):25-31. PubMed ID: 19246880
    [TBL] [Abstract][Full Text] [Related]  

  • 72. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
    Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
    Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
    Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
    J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
    Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
    J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
    O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
    J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT.
    Zhao S; Kuge Y; Kohanawa M; Takahashi T; Zhao Y; Yi M; Kanegae K; Seki K; Tamaki N
    J Nucl Med; 2008 Jan; 49(1):135-41. PubMed ID: 18077525
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ¹⁸F-FAMT in patients with multiple myeloma: clinical utility compared to ¹⁸F-FDG.
    Isoda A; Higuchi T; Nakano S; Arisaka Y; Kaira K; Kamio T; Mawatari M; Matsumoto M; Sawamura M; Tsushima Y
    Ann Nucl Med; 2012 Dec; 26(10):811-6. PubMed ID: 22903817
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer.
    Amano S; Inoue T; Tomiyoshi K; Ando T; Endo K
    J Nucl Med; 1998 Aug; 39(8):1424-7. PubMed ID: 9708521
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.